Skip to main content
. 2016 May 31;6:26983. doi: 10.1038/srep26983

Table 2. Stratified pooled relative risks and 95% confidence intervals for highest versus lowest category of dietary beta-carotene and all-cause mortality.

Subgroups N Death Participants RR 95%CI I2 (%) Pa Pb
All studies   7 11810 149774 0.83 0.78, 0.88 1.00 0.416  
Duration of follow-up                 0.144
  <10 years 5 4133 88170 0.89 0.80, 0.98 0 0.555  
  > = 10 years 2 7677 61604 0.79 0.73, 0.86 0 0.826  
Sample size                 0.902
  <10,000 3 1519 14341 0.83 0.70, 0.97 0 0.928  
  > = 10,000 4 10291 135433 0.84 0.75, 0.94 49.30 0.116  
Population age at baseline                 0.255
  <50 4 4434 86131 0.87 0.78, 0.97 14.50 0.320  
  > = 50 3 7376 63643 0.80 0.74, 0.86 0 0.843  
Median intake                 0.519
  <2500 ug/d 3 1762 48684 0.80 0.69, 0.92 0 0.722  
  > = 2500 ug/d 3 9729 94075 0.86 0.75, 0.99 60.80 0.078  
Validated FFQ                 0.751
  Yes 4 10019 130819 0.83 0.74, 0.93 42.70 0.155  
  No 3 1791 18955 0.85 0.73, 1.00 0 0.741  
Major confounders adjusted                  
History of disease                 0.071
  Yes 4 3571 46812 0.79 0.73, 0.85 0 0.852  
  No 3 8239 102962 0.92 0.82, 1.03 0 0.920  
Smoking and drinking                 0.837
  Yes 5 10309 131994 0.83 0.76, 0.91 25.60 0.251  
  No 2 1501 17780 0.85 0.72, 1.00 0 0.451  
Physical activity                 0.158
  Yes 4 8210 109615 0.80 0.74, 0.86 0 0.629  
  No 3 3600 40159 0.89 0.80, 1.00 0 0.457  
Serum cholesterol level                 0.751
  Yes 3 1791 18955 0.85 0.73, 1.00 0 0.741  
  No 4 10019 130819 0.83 0.74, 0.93 42.70 0.155  
Vitamin supplementation use                 0.302
  Yes 2 7057 56628 0.79 0.73, 0.86 0 0.574  
  No 5 4753 93146 0.87 0.79, 0.96 0 0.461  

Abbreviation: RR, relative risk; CI, confidence interval; I 2, measure of heterogeneity; Pa, P value for heterogeneity within each group; Pb, P value for heterogeneity between subgroups in meta-regression.